JournalsHub
.online
Find My Journal
IM

Isabelle Meaux

Independent Researcher

38
Publications
488
Citations
3
H-Index
3
i10-Index
0
2yr Mean Cite
-
Cite/Paper
Data combined from OpenAlex + Semantic Scholar. OA = OpenAlex S2 = Semantic Scholar
Verify on Google Scholar

Publication & Citation Trends

Publications

38 total

421 (PB409): XPR1, key regulator of phosphate homeostasis is a potential drug target for ovarian and lung cancer

P. Pannier, Abhishek Kumar, A. Lebsir, Vincent Ogor, Emmanuel Calvet et al. - European Journal of Cancer, 2024
Cited by 0 OpenAlex

Abstract 6033: RA123, a new GLS1 allosteric inhibitor demonstrates in vitro and in vivo activity in multiple myeloma models

Christophe Henry, Dimitri Gorge-Bernat, Pascal Pannier, Isabelle Meaux, Jane Cheng - Cancer Research, 2023
Cited by 0 Semantic Scholar

Correction: SAR405838: A Novel and Potent Inhibitor of the MDM2:p53 Axis for the Treatment of Dedifferentiated Liposarcoma OA

K. Bill, J. Garnett, Isabelle Meaux, Xiao-yi Ma, C. Creighton - Clinical Cancer Research, 2022
Cited by 3 Semantic Scholar

Abstract 2125: Roles of KAT6A and KAT6B in the biology of estrogen positive breast cancer

Isabelle Meaux, Dimitri Gorge-Bernat, Angele Paz, Catherine Geslin, L. Debussche - Molecular and Cellular Biology/Genetics, 2021
Cited by 0 Semantic Scholar

Abstract 242: Identification of biomarkers predicting sensitivity to GLS1 inhibition using a CRISPR screen

Christophe Henry, K. Berthelot, C. Lanneau, C. Orsini, Dimitri Gorge-Bernat - Molecular and Cellular Biology / Genetics, 2020
Cited by 0 Semantic Scholar

Abstract 3070: Discovery of novel potent allele-selective KRAS-G12C covalent inhibitors stemming from DNA-encoded library

Gary McCort, Rosalía Arrebola, Loreley Calvet, Baptiste Ronan, Fabrice Vergne et al. - Cancer Research, 2019
Cited by 1 OpenAlex

Efficacy of the MDM2 Inhibitor SAR405838 in Glioblastoma Is Limited by Poor Distribution Across the Blood–Brain Barrier PDF

Minjee Kim, J. Daniel, David Calligaris, Shuangling Zhang, Ryan W. Feathers et al. - Molecular Cancer Therapeutics, 2018
Cited by 40 OpenAlex

SAR405838: A Novel and Potent Inhibitor of the MDM2:p53 Axis for the Treatment of Dedifferentiated Liposarcoma PDF

Kate Lynn J. Bill, Jeannine Garnett, Isabelle Meaux, XiaoYen Ma, Chad J. Creighton et al. - Clinical Cancer Research, 2015
Cited by 106 OpenAlex

SAR405838: An Optimized Inhibitor of MDM2–p53 Interaction That Induces Complete and Durable Tumor Regression PDF

Shaomeng Wang, Wei Sun, Yujun Zhao, Donna McEachern, Isabelle Meaux et al. - Cancer Research, 2014
Cited by 337 OpenAlex

SAR405838: an optimized inhibitor of MDM2-p53 interaction that induces complete and durable tumor regression. OA

Shaomeng Wang, Wei Sun, Yujun Zhao, D. McEachern, Isabelle Meaux - Cancer Research, 2014
Cited by 264 Semantic Scholar

Research Topics

Sarcoma Diagnosis and Treatment (17) Cancer-related Molecular Pathways (14) Glioma Diagnosis and Treatment (6) Cancer Genomics and Diagnostics (5) Cancer Research and Treatments (4)

Affiliations

Sanofi (France)
FR 2023 - 2012

External Profiles

OpenAlex Profile Semantic Scholar Profile Google Scholar

Share Profile

Back to Researchers
Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now